DrugRisk Updates Legal Info on Byetta Lawsuits As Initial Hearing Set

Share Article

The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

byetta lawsuit
In 2011, a study from UCLA suggested subjects given Byetta may have higher occurrences of pancreatic cancer and thyroid cancer.

The diabetes drug resource center at DrugRisk.com is announcing updated information for patients taking the medication Byetta. After lawsuits alleging the drug caused cancer were consolidated to a special court*, that court has now scheduled an initial hearing for later this month.

DrugRisk is a free resource for patients taking popular prescription drugs. By providing the latest updates on product recalls, safety alerts, research and litigation news, they can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.

Byetta is a popular injectable medication prescribed to those with type-II diabetes to lower blood sugar levels. However, the resource center has added information showing experts disagree about its safety.

In 2011, a study from UCLA suggested subjects given Byetta may have higher occurrences of pancreatic cancer and thyroid cancer**. This year, the Journal for the American Medical Association also advised that drugs like Byetta can double the risk of pancreatitis, a major risk factor for pancreatic cancer***.

The Institute for Safe Medication Practices has attributed a majority of serious diabetes drug side effect reports to the FDA to Byetta****. However, the FDA has not issued a recall or required new label warnings.

Due to the growing number of patients who have filed a Byetta lawsuit alleging cancer, cases were consolidated to a special multidistrict litigation federal court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California). The latest court records show 60 cases have already been filed over Byetta, Januvia, Janumet or Victoza*.

Now, according to a court order dated September 11, 2013, the MDL court has scheduled the litigation’s initial conference for October 17, 2013.

Anyone affected by cancer after taking Byetta is encouraged to visit the DrugRisk center or speak with a lawyer about their legal options. However, DrugRisk only recommends lawyers who have already handled these complex Byetta lawsuits."

For more information on the research, side effects and litigation news related to Byetta and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*JPML 9/11/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-September-11-2013.pdf
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****ISMP QuarterWatch April, 2013.ismp.org/QuarterWatch/pdfs/2012Q3.pdf

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Schroeder
DrugRisk
888-415-1859
Email >
Visit website